New Spinal Fusion Rod Developed by ZIAN receives FDA Approval

New Sinu-Lok Spinal Fusion Rod Developed by MUSC Neuroscience Institute Receives FDA Approval

“Sinu-Lok.” ZIAN Zucker Institute for Applied Neurosciences

A uniquely curved titanium rod, developed by Zucker Institute for Applied Neurosciences (ZIAN) at the Medical University of South Carolina (MUSC), to improve lumbar spinal fusion can be used in surgery after receiving approval from the U.S. Food and Drug Administration (FDA).

Upstream Partners was instrumental in the creation and funding of ZIAN, by writing the business plan, raising the funding, and devising the unique relationship between a not-for-profit entity, ZIAN, and a for-profit technology accelerator.

Click here to view the article